GlaxoSmithKline’s Revenue Was Flat in Second Quarter
GlaxoSmithKline (GSK) reported revenues of 7.3 billion pounds during the second quarter of 2018, nearly flat as compared to the second quarter of 2017. Revenues rose 4% at constant exchange rates, offset by a 4% negative impact of foreign exchange. The strengthening of the pound negatively affected overall revenues during the second quarter of 2018.